Checks are being mailed to Provigil consumers in connection with the settlement between Vermont and 47 other states, and drug company Cephalon and affiliated companies (now part of Teva Pharmaceutical Industries). Following federal court approval of the settlement, Provigil consumers who purchased Provigil during the time period covered by the settlement were provided with notice and an opportunity to participate in, object to, or opt out of the settlement. In order to participate, consumers were required to submit written claims regarding their Provigil purchases.
A court-approved independent claims administrator reviewed the consumer claims and determined which claimants were entitled to receive settlement proceeds. The checks being sent to Vermont consumers reflect those consumers’ pro rata share of the settlement proceeds.
Additional Information about the settlement is available at:
Vermont Attorney General Urges Eligible Vermont Residents to Submit Claims for Provigil Settlement
Pharmaceutical Manufacturer Will Pay Vermont Over $1.6 Million As Part Of Provigil Antitrust Settlement
Last modified: February 14, 2018